• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OGDEN MANUFACTURING PLANT OPTIFLUX 200NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OGDEN MANUFACTURING PLANT OPTIFLUX 200NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Model Number 0500320E
Device Problem Fluid/Blood Leak (1250)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/10/2022
Event Type  malfunction  
Event Description
A user facility administrative assistant (aa) reported that a blood leak occurred immediately after the start of the patient¿s hemodialysis (hd) treatment.Upon additional follow-up, a registered nurse (rn), clarified the dialyzer blood leak occurred on (b)(6)2022 and was an internal blood leak within the dialyzer housing.The rn confirmed that the machine, a fresenius 2008t machine, alarmed appropriately with a "minor" blood leak alarm and treatment was immediately discontinued.Blood leak test strips were used and tested positive for the presence of blood.The rn also stated that fresenius bloodlines were used for treatment and confirmed no external blood leak was observed.The rn stated that there were no defects or damage seen on the dialyzer.Per rn the patient¿s blood was not returned and stated the estimated blood loss was 200cc.Immediately following the event, the patient was re-setup with new supplies on a different machine where the patient was able to complete treatment.The rn confirmed that there was no patient injury, adverse events, or medical intervention required as a result of the reported event.The dialyzer was no longer available to be returned for manufacturer evaluation.
 
Manufacturer Narrative
Plant investigation: the plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.
 
Event Description
A user facility administrative assistant (aa) reported that a blood leak occurred immediately after the start of the patient¿s hemodialysis (hd) treatment.Upon additional follow-up, a registered nurse (rn), clarified the dialyzer blood leak occurred on (b)(6)2022 and was an internal blood leak within the dialyzer housing.The rn confirmed that the machine, a fresenius 2008t machine, alarmed appropriately with a "minor" blood leak alarm and treatment was immediately discontinued.Blood leak test strips were used and tested positive for the presence of blood.The rn also stated that fresenius bloodlines were used for treatment and confirmed no external blood leak was observed.The rn stated that there were no defects or damage seen on the dialyzer.Per rn the patient¿s blood was not returned and stated the estimated blood loss was 200cc.Immediately following the event, the patient was re-setup with new supplies on a different machine where the patient was able to complete treatment.The rn confirmed that there was no patient injury, adverse events, or medical intervention required as a result of the reported event.The dialyzer was no longer available to be returned for manufacturer evaluation.
 
Manufacturer Narrative
Plant investigation: the reported complaint was not confirmed as the complaint device was not returned for manufacturer evaluation.A lot history review was performed.There were two other complaints reported against the lot.There was one complaint for two cracked dialyzers, no patient involvement (no sample).A review of the production record was performed.There was no indication of product nonacceptance, deviation, non-conformance, rework, labeling or process control failure during the manufacturing process which could be associated with the reported event.The lot met all release criteria.A definitive conclusion regarding the complaint incident cannot be reached without physical examination of the actual device.Therefore, the complaint is not confirmed.There is no recall associated with this complaint.Continuous improvement is of the utmost importance to fresenius medical care as we strive to provide dialysis products of the highest quality to our patients.Reports of leaking product are investigated both individually as complaints, as well as via the nc/capa program, in order to assess and improve our products and processes.Capas 2018-0171 (vision systems) and 2018-0161 (blood leak reduction) are recent examples of leak related investigations directed at an overall reduction in dialyzer leaks.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIFLUX 200NRE DIALYZER FINISHED ASSY.
Type of Device
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
OGDEN MANUFACTURING PLANT
director, site quality
475 west 13th street
ogden UT 84404
Manufacturer (Section G)
OGDEN MANUFACTURING PLANT
director, site quality
475 west 13th street
ogden UT 84404
Manufacturer Contact
jessica trujillo
920 winter st
waltham, MA 02451
6174175172
MDR Report Key15658940
MDR Text Key307005287
Report Number0001713747-2022-00447
Device Sequence Number1
Product Code KDI
UDI-Device Identifier00840861100163
UDI-Public00840861100163
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K162488
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Administrator/Supervisor
Type of Report Initial,Followup
Report Date 11/07/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/24/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number0500320E
Device Catalogue Number0500320E
Device Lot Number22EU04022
Was Device Available for Evaluation? No
Device AgeMO
Date Manufacturer Received11/07/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/05/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
FRESENIUS 2008T MACHINE; FRESENIUS 2008T MACHINE; FRESENIUS BLOODLINES; FRESENIUS BLOODLINES
Patient Age53 YR
Patient SexMale
-
-